Copyright
©The Author(s) 2023.
World J Clin Cases. Oct 6, 2023; 11(28): 6823-6830
Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6823
Published online Oct 6, 2023. doi: 10.12998/wjcc.v11.i28.6823
Table 1 Cases of pancreatic carcinoma associated with polymyositis and myopathy
| Ref. | Sex/age | Statin use | Clinical presentation | Cancer type | Diagnosis | Treatment | Gemcitabine use | Additional findings | Follow-up and outcome |
| Kida et al[19], 2007 | M, 53 | NR | Arthralgia | AK | CT | Steroids | No | Late-stage | Died 4 yr |
| Myalgias muscolar weakness | Biopsy | Fluorouracil radiotherapy | Carcinoma | After diagnosis | |||||
| Syrios et al[15], 2011 | M, 52 | NR | Weight loss | AK | CT | Steroids | Yes | - | Remission |
| Recurrent pancreatitis | EMG biopsy | Gemcitabine erlotinib | Six months (then relapse) | ||||||
| Siddiqui et al[20], 2011 | F, 86 | NR | Muscolar weakness | AK | CT | Steroids | No | - | Remission |
| Biopsy | Surgery | Six months | |||||||
| Amroun et al[21], 2012 | M, 47 | NR | Abdominal pain | AK | CT | Surgery | Yes | Myopathy | Remission |
| Jaundice weight loss asthenia | MRI Biopsy | Gemcitabine | Developed during 4th cycle of chemotherapy | Nine months, then death due to pneumonia | |||||
| Padniewski et al[22], 2020 | M, 66 | Yes | Generalized fatigue | AK | CT | Steroids | Yes, later in | Myopathy | Gemcitabine |
| Muscolar weakness loose stools weight loss | MRI | FOLFOX followed by gemcitabine | Course | Developed prior to gemcitabine | Trial died 1 mo later | ||||
| Decraene et al[23], 2021 | M, 69 | NR | Jaundice | NET | MRI | Steroids | No | - | Remission |
| Diarrhea weight loss | EMG biopsy | Surgery carboplatinum-etoposide | Six months (no recurrence) | ||||||
| Ozcan et al[24], 2022 | M, 86 | Yes | Myalgias | AK | MRI | Steroids | Yes, later in | Metastatic | Third line |
| Muscolar weakness | MRCP ERCP biopsy | Surgery FOLFOX followed by FOLFIRI | Course | Carcinoma | Palliative treatment (gemcitabine and abraxane) | ||||
| Present case, 2022 | F, 78 | Yes | Jaundice | Unknown | CT | Steroids | No | AKI treated with | Died during |
| Weight loss myalgias muscolar weakness | EMG | Replacement therapy | Hospitalization |
- Citation: Costantini A, Moletta L, Pierobon ES, Serafini S, Valmasoni M, Sperti C. Paraneoplastic myopathy-related rhabdomyolysis and pancreatic cancer: A case report and review of the literature. World J Clin Cases 2023; 11(28): 6823-6830
- URL: https://www.wjgnet.com/2307-8960/full/v11/i28/6823.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i28.6823
